SWOG clinical trial number
SWOG-8915
Study of 6-Thioguanine Administered as 120 Hour Continuous Infusion for Refractory or Recurrent Small Cell Lung Carcinoma
Closed
Phase
Accrual
63%
Published
Abbreviated Title
Study of 6-Thioguanine Administered as 120 Hour Continuous Infusion for Refractory or Recurrent Small Cell Lung Carcinoma
Activated
03/01/1990
Closed
12/15/1991
Publication Information Expand/Collapse
1993
Phase II trial of 6-thioguanine administered as 120 hour continuous infusion for refractory or recurrent small cell lung cancer: A Southwest Oncology Group study.